Medical Journals

Central Nicotinic Cholinergic Systems: a Role in the Cognitive Dysfunction in Attention-deficit/Hyperactivity Disorder?

Authors:
  • Potter Alexandra S
  • Newhouse Paul A
  • Bucci David J

From: Clinical Neuroscience Research Unit, Department of Psychiatry, College of Medicine, University of Vermont, 1 South Prospect Street, Burlington, VT 05401, United States. Alexandra.Potter@uvm.edu

Behavioural brain research

  • Publish Date: Dec 2006
  • ISSN: 0166-4328
  • Volume: 175
  • Issue: 2
  • Pages: 201-11
  • Medium: Print
  • Language: English
  • Citation (JAMA): Potter Alexandra S, Newhouse Paul A, Bucci David J, et al. Central Nicotinic Cholinergic Systems: a Role in the Cognitive Dysfunction in Attention-deficit/Hyperactivity Disorder?. Behav. Brain Res. Dec 2006;175:201-11

Abstract

Theories of the neurobiological basis of Attention-Deficit/Hyperactivity Disorder (ADHD) have largely focused on dysregulation of central dopaminergic function. However, other neurotransmitter systems may be implicated in specific cognitive deficits in ADHD. Interest in the potential involvement of nicotinic cholinergic systems in ADHD has arisen in part from the observation that adolescents and adults with ADHD smoke cigarettes at significantly higher rates than people without this disorder. In addition, several studies report that nicotine alleviates ADHD symptoms, and recent neuro-genetics studies indicate that cholinergic systems may be altered in persons with ADHD. In this review, we describe the evidence for a role of central nicotinic cholinergic systems in cognitive deficits in ADHD. We also propose mechanisms by which alterations in cholinergic function may contribute directly and/or indirectly to these deficits. Finally, we identify specific paradigms and models to guide future investigations into the specific involvement of nicotinic cholinergic systems in ADHD, possibly leading to the development of more effective pharmacotherapies for ADHD.

Mesh Headings (Keywords): Animals, Attention Deficit Disorder with Hyperactivity, Brain, Cognition Disorders, Dopamine, Humans, Receptors, Nicotinic, Smoking


Check for Full Text / PubMed Unique Identifier (PMID): 17081628


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.